Cargando…
The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
BACKGROUND: Prognosis in pulmonary arterial hypertension (PAH) is closely related to indexes of right ventricular function. A better understanding of their relationship may provide important implications for risk stratification in PAH. RESEARCH QUESTION: Can clinical network graphs inform risk strat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131051/ https://www.ncbi.nlm.nih.gov/pubmed/34774527 http://dx.doi.org/10.1016/j.chest.2021.10.045 |
_version_ | 1784713103531835392 |
---|---|
author | Haddad, Francois Contrepois, Kevin Amsallem, Myriam Denault, Andre Y. Bernardo, Roberto J. Jha, Alokkumar Taylor, Shalina Arthur Ataam, Jennifer Mercier, Olaf Kuznetsova, Tatiana Vonk Noordegraaf, Anton Zamanian, Roham T. Sweatt, Andrew J. |
author_facet | Haddad, Francois Contrepois, Kevin Amsallem, Myriam Denault, Andre Y. Bernardo, Roberto J. Jha, Alokkumar Taylor, Shalina Arthur Ataam, Jennifer Mercier, Olaf Kuznetsova, Tatiana Vonk Noordegraaf, Anton Zamanian, Roham T. Sweatt, Andrew J. |
author_sort | Haddad, Francois |
collection | PubMed |
description | BACKGROUND: Prognosis in pulmonary arterial hypertension (PAH) is closely related to indexes of right ventricular function. A better understanding of their relationship may provide important implications for risk stratification in PAH. RESEARCH QUESTION: Can clinical network graphs inform risk stratification in PAH? STUDY DESIGN AND METHODS: The study cohort consisted of 231 patients with PAH followed up for a median of 7.1 years. An undirected, correlation network was used to visualize the relationship between clinical features in PAH. This network was enriched for right heart parameters and included N-terminal pro-hormone B-type natriuretic peptide (NT-proBNP), comprehensive echocardiographic parameters, and hemodynamics, as well as 6-min walk distance (6MWD), vital signs, laboratory data, and diffusing capacity for carbon monoxide (Dlco). Connectivity was assessed by using eigenvector and betweenness centrality to reflect global and regional connectivity, respectively. Cox proportional hazards regression was used to model event-free survival for the combined end point of death or lung transplantation. RESULTS: A network of closely intertwined features centered around NT-proBNP with 6MWD emerging as a secondary hub were identified. Less connected nodes included Dlco, systolic BP, albumin, and sodium. Over the follow-up period, death or transplantation occurred in 92 patients (39.8%). A strong prognostic model was achieved with a Harrell’s C-index of 0.81 (0.77-0.85) when combining central right heart features (NT-proBNP and right ventricular end-systolic remodeling index) with 6MWD and less connected nodes (Dlco, systolic BP, albumin, sodium, sex, connective tissue disease etiology, and prostanoid therapy). When added to the baseline risk model, serial change in NT-proBNP significantly improved outcome prediction at 5 years (increase in C-statistic of 0.071 ± 0.024; P = .003). INTERPRETATION: NT-proBNP emerged as a central hub in the intertwined PAH network. Connectivity analysis provides explainability for feature selection and combination in outcome models. |
format | Online Article Text |
id | pubmed-9131051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American College of Chest Physicians |
record_format | MEDLINE/PubMed |
spelling | pubmed-91310512022-06-04 The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension Haddad, Francois Contrepois, Kevin Amsallem, Myriam Denault, Andre Y. Bernardo, Roberto J. Jha, Alokkumar Taylor, Shalina Arthur Ataam, Jennifer Mercier, Olaf Kuznetsova, Tatiana Vonk Noordegraaf, Anton Zamanian, Roham T. Sweatt, Andrew J. Chest Pulmonary Vascular: Original Research BACKGROUND: Prognosis in pulmonary arterial hypertension (PAH) is closely related to indexes of right ventricular function. A better understanding of their relationship may provide important implications for risk stratification in PAH. RESEARCH QUESTION: Can clinical network graphs inform risk stratification in PAH? STUDY DESIGN AND METHODS: The study cohort consisted of 231 patients with PAH followed up for a median of 7.1 years. An undirected, correlation network was used to visualize the relationship between clinical features in PAH. This network was enriched for right heart parameters and included N-terminal pro-hormone B-type natriuretic peptide (NT-proBNP), comprehensive echocardiographic parameters, and hemodynamics, as well as 6-min walk distance (6MWD), vital signs, laboratory data, and diffusing capacity for carbon monoxide (Dlco). Connectivity was assessed by using eigenvector and betweenness centrality to reflect global and regional connectivity, respectively. Cox proportional hazards regression was used to model event-free survival for the combined end point of death or lung transplantation. RESULTS: A network of closely intertwined features centered around NT-proBNP with 6MWD emerging as a secondary hub were identified. Less connected nodes included Dlco, systolic BP, albumin, and sodium. Over the follow-up period, death or transplantation occurred in 92 patients (39.8%). A strong prognostic model was achieved with a Harrell’s C-index of 0.81 (0.77-0.85) when combining central right heart features (NT-proBNP and right ventricular end-systolic remodeling index) with 6MWD and less connected nodes (Dlco, systolic BP, albumin, sodium, sex, connective tissue disease etiology, and prostanoid therapy). When added to the baseline risk model, serial change in NT-proBNP significantly improved outcome prediction at 5 years (increase in C-statistic of 0.071 ± 0.024; P = .003). INTERPRETATION: NT-proBNP emerged as a central hub in the intertwined PAH network. Connectivity analysis provides explainability for feature selection and combination in outcome models. American College of Chest Physicians 2022-05 2021-11-11 /pmc/articles/PMC9131051/ /pubmed/34774527 http://dx.doi.org/10.1016/j.chest.2021.10.045 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Pulmonary Vascular: Original Research Haddad, Francois Contrepois, Kevin Amsallem, Myriam Denault, Andre Y. Bernardo, Roberto J. Jha, Alokkumar Taylor, Shalina Arthur Ataam, Jennifer Mercier, Olaf Kuznetsova, Tatiana Vonk Noordegraaf, Anton Zamanian, Roham T. Sweatt, Andrew J. The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title | The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title_full | The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title_fullStr | The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title_full_unstemmed | The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title_short | The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension |
title_sort | right heart network and risk stratification in pulmonary arterial hypertension |
topic | Pulmonary Vascular: Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131051/ https://www.ncbi.nlm.nih.gov/pubmed/34774527 http://dx.doi.org/10.1016/j.chest.2021.10.045 |
work_keys_str_mv | AT haddadfrancois therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT contrepoiskevin therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT amsallemmyriam therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT denaultandrey therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT bernardorobertoj therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT jhaalokkumar therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT taylorshalina therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT arthurataamjennifer therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT mercierolaf therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT kuznetsovatatiana therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT vonknoordegraafanton therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT zamanianrohamt therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT sweattandrewj therightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT haddadfrancois rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT contrepoiskevin rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT amsallemmyriam rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT denaultandrey rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT bernardorobertoj rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT jhaalokkumar rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT taylorshalina rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT arthurataamjennifer rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT mercierolaf rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT kuznetsovatatiana rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT vonknoordegraafanton rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT zamanianrohamt rightheartnetworkandriskstratificationinpulmonaryarterialhypertension AT sweattandrewj rightheartnetworkandriskstratificationinpulmonaryarterialhypertension |